[1] |
|
[2] |
O'CAOIMH R, SEZGIN D, O'DONOVAN M R,et al. Prevalence of frailty in 62 countries across the world:a systematic review and meta-analysis of population-level studies[J]. Age Ageing, 2021, 50(1):96-104. DOI: 10.1093/ageing/afaa219.
|
[3] |
LIU H X, DING G, YU W J,et al. Association between frailty and incident risk of disability in community-dwelling elder people:evidence from a meta-analysis[J]. Public Health, 2019, 175:90-100. DOI: 10.1016/j.puhe.2019.06.010.
|
[4] |
HANLON P, NICHOLL B I, JANI B D,et al. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality:a prospective analysis of 493 737 UK Biobank participants[J]. Lancet Public Health, 2018, 3(7):e323-332. DOI: 10.1016/S2468-2667(18)30091-4.
|
[5] |
AGUAYO G A, VAILLANT M T, DONNEAU A F,et al. Comparative analysis of the association between 35 frailty scores and cardiovascular events,cancer,and total mortality in an elderly general population in England:an observational study[J]. PLoS Med, 2018, 15(3):e1002543. DOI: 10.1371/journal.pmed.1002543.
|
[6] |
IMTIAZ F, SHAFIQUE K, MIRZA S S,et al. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population[J]. Int Arch Med, 2012, 5(1):2. DOI: 10.1186/1755-7682-5-2.
|
[7] |
ÖZTÜRK Z A, ÜNAL A, YI\U011FITER R,et al. Is increased red cell distribution width (RDW) indicating the inflammation in Alzheimer's disease (AD)? [J]. Arch Gerontol Geriatr, 2013, 56(1):50-54. DOI: 10.1016/j.archger.2012.10.002.
|
[8] |
LI C M, CHAO C T, CHEN S I,et al. Elevated red cell distribution width is independently associated with a higher frailty risk among 2,932 community-dwelling older adults[J]. Front Med (Lausanne), 2020, 7:470. DOI: 10.3389/fmed.2020.00470.
|
[9] |
HOU P, XUE H P, MAO X E,et al. Inflammation markers are associated with frailty in elderly patients with coronary heart disease[J]. Aging (Albany NY), 2018, 10(10):2636-2645. DOI: 10.18632/aging.101575.
|
[10] |
WANG J, HUANG L J, XU M C,et al. Study on the clinical implications of NLR and PLR for diagnosing frailty in maintenance hemodialysis patients and their correlations with patient prognosis[J]. J Healthc Eng, 2022, 2022:1267200. DOI: 10.1155/2022/1267200.
|
[11] |
SANCHIS J, NÚÑEZ E, RUIZ V,et al. Usefulness of clinical data and biomarkers for the identification of frailty after acute coronary syndromes[J]. Can J Cardiol, 2015, 31(12):1462-1468. DOI: 10.1016/j.cjca.2015.07.737.
|
[12] |
DAUDT H M L, VAN MOSSEL C, SCOTT S J. Enhancing the scoping study methodology:a large,inter-professional team's experience with Arksey and O'Malley's framework[J]. BMC Med Res Methodol, 2013, 13:48. DOI: 10.1186/1471-2288-13-48.
|
[13] |
STANG A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses[J]. Eur J Epidemiol, 2010, 25(9):603-605. DOI: 10.1007/s10654-010-9491-z.
|
[14] |
ROSTOM A, DUBE C, CRANNEY A,et al. Celiac disease[J]. Evid Rep Technol Assess(Summ),2004(104):1-6.
|
[15] |
HU J D, DONG Y H, CHEN X D,et al. Prevalence of suicide attempts among Chinese adolescents:a meta-analysis of cross-sectional studies[J]. Compr Psychiatry, 2015, 61:78-89. DOI: 10.1016/j.comppsych.2015.05.001.
|
[16] |
ZHANG H, HAO M, HU Z X,et al. Association of immunity markers with the risk of incident frailty:the Rugao longitudinal aging study[J]. Immun Ageing, 2022, 19(1):1. DOI: 10.1186/s12979-021-00257-6.
|
[17] |
GILMORE N, MOHILE S, LEI L L,et al. The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy[J]. Breast Cancer Res, 2021, 23(1):19. DOI: 10.1186/s13058-021-01388-w.
|
[18] |
GIRI S, DAHAL S, BAL S,et al. Pre-treatment neutrophil to lymphocyte ratio as a biomarker of frailty and predictor of survival among older adults with multiple myeloma[J]. J Geriatr Oncol, 2022, 13(4):486-492. DOI: 10.1016/j.jgo.2021.12.004.
|
[19] |
BILGIN S, AKTAS G, KAHVECI G,et al. Does mean platelet volume/lymphocyte count ratio associate with frailty in type 2 diabetes mellitus? [J]. Bratisl Lek Listy, 2021, 122(2):116-119. DOI: 10.4149/BLL_2021_017.
|
[20] |
XU W H, LIANG Y F, LIN Z Y. Association between neutrophil-lymphocyte ratio and frailty:the Chinese longitudinal healthy longevity survey[J]. Front Med (Lausanne), 2022, 8:783077. DOI: 10.3389/fmed.2021.783077.
|
[21] |
BODOLEA C, HIRISCAU E I, BUZDUGAN E C,et al. The association between peripheral blood cells and the frailty syndrome in patients with cardiovascular diseases[J]. Endocr Metab Immune Disord Drug Targets, 2020, 20(9):1419-1433. DOI: 10.2174/1871530320666200813135905.
|
[22] |
NISHIJIMA T F, DEAL A M, WILLIAMS G R,et al. Frailty and inflammatory markers in older adults with cancer[J]. Aging (Albany NY), 2017, 9(3):650-664. DOI: 10.18632/aging.101162.
|
[23] |
LI Q P, CHEN X, HAN B R. Red blood cell distribution width is associated with frailty in older inpatients in China:sex differences in a cross-sectional study[J]. Exp Gerontol, 2021, 150:111392. DOI: 10.1016/j.exger.2021.111392.
|
[24] |
QU J L, ZHOU T, XUE M X,et al. Correlation analysis of hemoglobin-to-red blood cell distribution width ratio and frailty in elderly patients with coronary heart disease[J]. Front Cardiovasc Med, 2021, 8:728800. DOI: 10.3389/fcvm.2021.728800.
|
[25] |
KIM K M, LUI L Y, BROWNER W S,et al. Association between variation in red cell size and multiple aging-related outcomes[J]. J Gerontol A Biol Sci Med Sci, 2021, 76(7):1288-1294. DOI: 10.1093/gerona/glaa217.
|
[26] |
LENG S A, CHAVES P, KOENIG K,et al. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty:a pilot study[J]. J Am Geriatr Soc, 2002, 50(7):1268-1271. DOI: 10.1046/j.1532-5415.2002.50315.x.
|
[27] |
FULOP T, MCELHANEY J, PAWELEC G,et al. Frailty,inflammation and immunosenescence[J]. Interdiscip Top Gerontol Geriatr, 2015, 41:26-40. DOI: 10.1159/000381134.
|
[28] |
FULOP T, LARBI A, DUPUIS G,et al. Immunosenescence and inflamm-aging as two sides of the same coin:friends or foes? [J]. Front Immunol, 2018, 8:1960. DOI: 10.3389/fimmu.2017.01960.
|
[29] |
FERRUCCI L, FABBRI E. Inflammageing:chronic inflammation in ageing,cardiovascular disease,and frailty[J]. Nat Rev Cardiol, 2018, 15(9):505-522. DOI: 10.1038/s41569-018-0064-2.
|
[30] |
WALKER K A, WALSTON J, GOTTESMAN R F,et al. Midlife systemic inflammation is associated with frailty in later life:the ARIC study[J]. J Gerontol A Biol Sci Med Sci, 2019, 74(3):343-349. DOI: 10.1093/gerona/gly045.
|
[31] |
DENT E, LIEN C, LIM W S,et al. The Asia-Pacific clinical practice guidelines for the management of frailty[J]. J Am Med Dir Assoc, 2017, 18(7):564-575. DOI: 10.1016/j.jamda.2017.04.018.
|
[32] |
PARK J W, CHANG H J, YEO H Y,et al. The relationships between systemic cytokine profiles and inflammatory markers in colorectal cancer and the prognostic significance of these parameters[J]. Br J Cancer, 2020, 123(4):610-618. DOI: 10.1038/s41416-020-0924-5.
|
[33] |
VASSILAKOS G, BARTON E. Insulin-like growth factor I regulation and its actions in skeletal muscle[J]. Compr Physiol,2018,9(1):413-438.
|
[34] |
LAZARUS D D, MOLDAWER L L, LOWRY S F. Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha,tumor necrosis factor-alpha,and interleukin-6[J]. Lymphokine Cytokine Res,1993,12(4):219-223.
|
[35] |
VAN NIEUWPOORT I C, VLOT M C, SCHAAP L A,et al. The relationship between serum IGF-1,handgrip strength,physical performance and Falls in elderly men and women[J]. Eur J Endocrinol, 2018, 179(2):73-84. DOI: 10.1530/EJE-18-0076.
|
[36] |
FEST J, RUITER R, IKRAM M A,et al. Reference values for white blood-cell-based inflammatory markers in the Rotterdam Study:a population-based prospective cohort study[J]. Sci Rep, 2018, 8(1):10566. DOI: 10.1038/s41598-018-28646-w.
|
[37] |
FARIA S S, FERNANDES P C Jr, SILVA M J,et al. The neutrophil-to-lymphocyte ratio:a narrative review[J]. Ecancermedicalscience, 2016, 10:702. DOI: 10.3332/ecancer.2016.702.
|
[38] |
DINKLA S, VAN EIJK L T, FUCHS B,et al. Inflammation-associated changes in lipid composition and the organization of the erythrocyte membrane[J]. BBA Clin, 2016, 5:186-192. DOI: 10.1016/j.bbacli.2016.03.007.
|
[39] |
STRAAT M, VAN BRUGGEN R, DE KORTE D,et al. Red blood cell clearance in inflammation[J]. Transfus Med Hemother, 2012, 39(5):353-361. DOI: 10.1159/000342229.
|
[40] |
BARTOLÁK-SUKI E, IMSIROVIC J, NISHIBORI Y,et al. Regulation of mitochondrial structure and dynamics by the cytoskeleton and mechanical factors[J]. Int J Mol Sci, 2017, 18(8):E1812. DOI: 10.3390/ijms18081812.
|
[41] |
SALVAGNO G L, SANCHIS-GOMAR F, PICANZA A,et al. Red blood cell distribution width:a simple parameter with multiple clinical applications[J]. Crit Rev Clin Lab Sci, 2015, 52(2):86-105. DOI: 10.3109/10408363.2014.992064.
|
[42] |
LUO R B, HU J, JIANG L B,et al. Prognostic value of red blood cell distribution width in non-cardiovascular critically or acutely patients:a systematic review[J]. PLoS One, 2016, 11(12):e0167000. DOI: 10.1371/journal.pone.0167000.
|
[43] |
KIM J, IM J S, CHOI C H,et al. The association between red blood cell distribution width and sarcopenia in US adults[J]. Sci Rep, 2018, 8(1):11484. DOI: 10.1038/s41598-018-29855-z.
|
[44] |
KATSAROU A, PANTOPOULOS K. Hepcidin therapeutics[J]. Pharmaceuticals (Basel), 2018, 11(4):E127. DOI: 10.3390/ph11040127.
|
[45] |
CAMASCHELLA C, NAI A, SILVESTRI L. Iron metabolism and iron disorders revisited in the hepcidin era[J]. Haematologica, 2020, 105(2):260-272. DOI: 10.3324/haematol.2019.232124.
|
[46] |
SOYSAL P, ISIK A T, CARVALHO A F,et al. Oxidative stress and frailty:a systematic review and synthesis of the best evidence[J]. Maturitas, 2017, 99:66-72. DOI: 10.1016/j.maturitas.2017.01.006.
|